Reuters Health News Summary

Following is a summary of current health news briefs.

Allergies, extra weight tied to bullying

NEW YORK (Reuters Health) - Kids who have food allergies or

are overweight may be especially likely to get bullied by their

peers, two new studies suggest. Not surprisingly, researchers

also found targets of bullying were more distressed and anxious

and had a worse quality of life, in general, than those who

weren't picked on.

Link between pot, psychosis goes both ways in kids

NEW YORK (Reuters Health) - Marijuana (cannabis) use may be

linked to the development of psychotic symptoms in teens - but

the reverse could also be true: psychosis in adolescents may be

linked to later pot use, according to a new Dutch study. "We

have focused mainly on temporal order; is it the chicken or the

egg? As the study shows, it is a bidirectional relationship,"

wrote the study's lead author Merel Griffith-Lendering, a

doctoral candidate at Leiden University in The Netherlands, in

an email to Reuters Health.

One in 12 in military has clogged heart arteries

NEW YORK (Reuters Health) - Just over one in 12 U.S.

service members who died in the Iraq and Afghanistan wars had

plaque buildup in the arteries around their hearts - an early

sign of heart disease, according to a new study. None of them

had been diagnosed with heart disease before deployment,

researchers said.

Obesity declining in young, poorer kids: study

NEW YORK (Reuters Health) - The number of low-income

preschoolers who qualify as obese or "extremely obese" has

dropped over the last decade, new data from the Centers for

Disease Control and Prevention show. Although the decline was

only "modest" and may not apply to all children, researchers

said it was still encouraging.

Japan approves Novo's new combination insulin Ryzodeg

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk

said on Tuesday Japan's health regulator had

approved its new combination insulin, that it plans to market

as Ryzodeg, for the treatment of diabetes. Ryzodeg is a

combination of Novo's new ultra long-acting insulin degludec,

or Tresiba, which Japan became the first country to approve in

September, and its rapid-acting insulin Novorapid.

UCB gets Japan clearance for two new drugs

BRUSSELS (Reuters) - Belgian pharmaceutical company UCB

has secured two regulatory clearances in Japan,

further cementing its worldwide shift to a new generation of

drugs. The company said in a statement on Tuesday that the

Japanese Ministry of Health, Labour and Welfare had approved

UCB's Neupro patch to treat Parkinson's disease and

moderate-to-severe Restleg Legs Syndrome in adults.

U.S. reprimands some eye centers on LASIK surgery

advertising

2012-12-24T172702Z_1_BRE8BN0J5_RTROPTC_0_US-FDA-LASIK-SURGERY.X

ML () -

FDA approves Aegerion's cholesterol drug with strongest

warning

2012-12-24T152508Z_1_BRE8BN0GR_RTROPTC_0_US-AEGERION-FDA-LIPIDD

RUG.XML () -

'Dystextia': Gibberish texts sound stroke alarm

NEW YORK (Reuters Health) - Imagine you were a devoted

husband, waiting to hear from your wife about her due date

after a visit to the obstetrician, and you saw these on your

phone: "every where thinging days nighing"

Little change in overtreatment at doctors' offices

NEW YORK (Reuters Health) - Although some Americans are

getting more of beneficial treatments that were underused in

the past, including drugs for heart disease, others are still

being overtested or overtreated for a range of conditions,

according to a new study. Researchers found U.S. doctors'

offices made progress on six of nine "quality indicators" for

recommended and underused therapies but only scaled back on two

of 11 unnecessary and potentially harmful health services.